retatrutide weight loss study results Lilly's triple agonist achieves 16.8% in phase 3 trial Retatrutide vs Tirzepatide (2026): Differences
Description
According to the platform's FAQ, your provider can modify your dosage at any time based on your medical history, progress, and goals
15 In terms of their overall effect, these changes seem not worthwhile
Endogenous GLP-1 production occurs in the L-cells of the distal ileum and colon in response to meals
Use your provider support - ask questions and stay engaged
There have been no official health warnings from doctors or government agencies regarding gastrointestinal side effects
MNT also spoke with Mir Ali, MD, a board-certified bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, who was also not involved in this study, about its findings
